Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Metabolic Insufficiency (TAMING) Glaucoma Study : a 2-year Multi-centre, Double-masked, Randomised, Placebo-controlled Trial of Nicotinamide (Vitamin B3) Supplementation in Glaucoma

NCT06731582 is registered in ClinicalTrials.gov with Singapore Eye Research Institute as lead sponsor.

NCT NCT06731582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06731582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Metabolic Insufficiency (TAMING) Glaucoma Study : a 2-year Multi-centre, Double-masked, Randomised, Placebo-controlled Trial of Nicotinamide (Vitamin B3) Supplementation in Glaucoma
Lead sponsor
Singapore Eye Research Institute
Phase
Phase 3
Overall status
Enrolling by invitation
Start date
March 12, 2024
Completion date
July 31, 2028
Enrollment
520 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma